CUSIP: 28202V108
What is CUSIP 28202V108?
CUSIP 28202V108 identifies EFTR - EFFECTOR THERAPEUTICS INC - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 28202V108:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q4 | 0 | $0 | -$2,041 | 0 | |
| 2024 Q3 | 52,343 | $2,041 | -$19,651 | $0.04 | 1 |
| 2024 Q2 | 120,081 | $34,836 | $0.29 | 2 | |
| 2024 Q1 | 120,081 | $1,727,966 | -$45,506,355 | $14.39 | 2 |
| 2023 Q4 | 11,685,202 | $5,436,632 | -$6,444,841 | $0.47 | 22 |
| 2023 Q3 | 23,453,478 | $13,978,203 | -$629,282 | $0.60 | 27 |
| 2023 Q2 | 24,403,703 | $20,139,361 | +$705,349 | $0.83 | 31 |
| 2023 Q1 | 23,584,988 | $8,289,026 | +$1,591,808 | $0.35 | 25 |
| 2022 Q4 | 24,320,898 | $10,420,597 | +$41,716 | $0.43 | 29 |
| 2022 Q3 | 23,952,489 | $13,657,000 | -$461,111 | $0.57 | 26 |
| 2022 Q2 | 24,109,298 | $33,849,146 | +$2,203,070 | $1.42 | 22 |
| 2022 Q1 | 22,473,064 | $89,709,363 | +$4,147,165 | $4.01 | 16 |
| 2021 Q4 | 20,093,195 | $166,371,000 | +$373,740 | $8.28 | 16 |
| 2021 Q3 | 13,427,760 | $127,452,546 | +$127,392,000 | $14.04 | 11 |